20 /100
LOW RISK
Score updated May 30, 2026

KYMR — Kymera Therapeutics, Inc. Dilution Risk Tracker

Track KYMR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KYMR — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
20
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for KYMR.
🔔 Track KYMR — Get forecast alerts →

💹 Market Data

Market Cap$6.70B
Shares Outstanding82.26M
Float55.05M
Cash$650.93M
Debt$80.47M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 11.6% shares (2025Q4 vs prior)
256 institutional holders · 91.69M shares
#1 FMR LLC 8.93M shares
#2 BAKER BROS. ADVISORS LP 8.66M shares
#3 Avoro Capital Advisors LLC 7.47M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest10.00M
Days to Cover21.3
% of Float18.2%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2020
4 INSIDER TRANSACTION Apr 29, 2026
4 INSIDER TRANSACTION Apr 24, 2026
4 INSIDER TRANSACTION Apr 24, 2026
4 INSIDER TRANSACTION Apr 16, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track KYMR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KYMR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for KYMR
📊 KYMR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 KYMR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.